GM
Geoff Meacham BofA Securities Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
64
Avg Return
Past Year
Past Year
14%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
72.7%
Neutral
27.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Technology
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Technology
Scientific & Technical Instruments
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $8 |
310%
upside
| 1 | +20% |
0
%
| 18 Nov ‘25 8 days ago |
|
|
|
Buy
Maintained
| $98 |
9%
upside
| 2 | +19% |
0
%
| 10 Nov ‘25 16 days ago |
|
|
|
Neutral
Maintained
| $75 |
13%
downside
| 1 | – |
–
| 5 Nov ‘25 21 days ago |
|
|
|
Neutral
Maintained
| $235 |
3%
upside
| 2 | +2.2% |
0
%
| 3 Nov ‘25 23 days ago |
|
|
|
Buy
Maintained
| $700 |
11%
downside
| 2 | +9.1% |
0
%
| 29 Oct ‘25 28 days ago |
|
|
|
Neutral
Downgraded
| $72 |
1%
upside
| 2 | +11% |
0
%
| 27 Oct ‘25 1 month ago |
|
|
|
Neutral
Maintained
| $28 |
12%
upside
| 1 | – |
–
| 23 Oct ‘25 1 month ago |
|
|
|
Buy
Maintained
| $50 |
21%
upside
| 1 | +49% |
0
%
| 17 Oct ‘25 1 month ago |
|
|
|
Buy
Maintained
| $80 |
18%
upside
| 1 | -1% |
0
%
| 17 Oct ‘25 1 month ago |
|
|
|
Buy
Maintained
| $50 |
18%
upside
| 1 | +41% |
0
%
| 17 Oct ‘25 1 month ago |
|
|
|
Buy
Maintained
| $20 |
33%
upside
| 3 | +32% |
0
%
| 17 Oct ‘25 1 month ago |
|
|
|
Buy
Maintained
| $93 |
74%
upside
| 1 | +12% |
0
%
| 17 Oct ‘25 1 month ago |
|
|
|
Neutral
Reinstated
| $95 |
9%
downside
| 1 | – |
–
| 13 Oct ‘25 1 month ago |
|
|
|
Buy
Maintained
| $135 |
6%
upside
| 1 | +9.2% |
0
%
| 8 Oct ‘25 1 month ago |
|
|
|
Buy
Maintained
| $575 |
33%
upside
| 1 | +6.9% |
0
%
| 2 Oct ‘25 1 month ago |
|
|
|
Buy
Upgraded
| $14 |
119%
upside
| 1 | +44% |
0
%
| 27 Aug ‘25 3 months ago |
|